Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 9 results.
User Information
Export Records
  1. 1.   Immunological monitoring of the tumor immunoenvironment for clinical trials
  2. Malyguine, A. M.; Strobl, S. L.; Shurin, M. R.
  3. Cancer Immunology Immunotherapy. 2012, Feb; 61(2): 239-247.
  1. 2.   IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors
  2. Kerkar, S. P.; Goldszmid, R. S.; Muranski, P.; Chinnasamy, D.; Yu, Z. Y.; Reger, R. N.; Leonardi, A. J.; Morgan, R. A.; Wang, E.; Marincola, F. M.; Trinchieri, G.; Rosenberg, S. A.; Restifo, N. P.
  3. Journal of Clinical Investigation. 2011, Dec; 121(12): 4746-4757.
  1. 3.   Highlights of 10 years of immunology in Nature Reviews Immunology
  2. Medzhitov, R.; Shevach, E. M.; Trinchieri, G.; Mellor, A. L.; Munn, D. H.; Gordon, S.; Libby, P.; Hansson, G. K.; Shortman, K.; Dong, C.; Gabrilovich, D.; Gabrysova, L.; Howes, A.; O'Garra, A.
  3. Nature Reviews Immunology. 2011, Oct; 11(10): 693-702.
  1. 4.   FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer
  2. Watkins, S. K.; Zhu, Z. Q.; Riboldi, E.; Shafer-Weaver, K. A.; Stagliano, K. E. R.; Sklavos, M. M.; Ambs, S.; Yagita, H.; Hurwitz, A. A.
  3. Journal of Clinical Investigation. 2011, Apr; 121(4): 1361-1372.
  1. 5.   Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophages
  2. Buhtoiarov, I. N.; Sondel, P. M.; Wigginton, J. M.; Buhtoiarova, T. N.; Yanke, E. M.; Mahvi, D. A.; Rakhmilevich, A. L.
  3. Immunology. 2011, Feb; 132(2): 226-239.
  1. 6.   Tumor-Specific CD8(+) T Cells Expressing Interleukin-12 Eradicate Established Cancers in Lymphodepleted Hosts
  2. Kerkar, S. P.; Muranski, P.; Kaiser, A.; Boni, A.; Sanchez-Perez, L.; Yu, Z. Y.; Palmer, D. C.; Reger, R. N.; Borman, Z. A.; Zhang, L.; Morgan, R. A.; Gattinoni, L.; Rosenberg, S. A.; Trinchieri, G.; Restifo, N. P.
  3. Cancer Research. 2010, Sep; 70(17): 6725-6734.
  1. 7.   Functional plasticity of macrophages: in situ reprogramming of tumor-associated macrophages
  2. Stout, R. D.; Watkins, S. K.; Suttles, J.
  3. Journal of Leukocyte Biology. 2009 86(5): 1105-1109.
  1. 8.   Successful immunotherapy with IL-2/anti-CD40 induces the chemokine-mediated mitigation of an immunosuppressive tumor microenvironment
  2. Weiss, J. M.; Back, T. C.; Scarzello, A. J.; Subleski, J. J.; Hall, V. L.; Stauffer, J. K.; Chen, X.; Micic, D.; Alderson, K.; Murphy, W. J.; Wiltrout, R. H.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2009 106(46): 19455-19460.
  1. 9.   T cell tolerance to tumors and cancer immunotherapy
  2. Shafer-Weaver, K.; Anderson, M.; Malyguine, A.; Hurwitz, A. A.
  3. Immune-Mediated Diseases: From Theory to Therapy. 2007; 601 : 357-368.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel